Paul J Riviere (Paul Riviere)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Cancer

Prostate cancer and prostatic diseases

The Journal of urology

Journal of the National Cancer Institute

UC San Diego Health System

University of California San Diego School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UC San Diego Health System

United States

Resident :: Radiation Medicine and Applied Sciences

UC Irvine Health

United States

Resident :: Internal Medicine

Education History

University of California San Diego School of Medicine

United States

PHD

Stanford University

United States

BSC :: Biology

Publications

Paul J Riviere, Leah N Deshler, Kylie M Morgan, Edmund M Qiao, Alex K Bryant, Brent S Rose
Reply by Authors. The Journal of urology (2024)
Paul J Riviere, Leah N Deshler, Kylie M Morgan, Edmund M Qiao, Alex K Bryant, Brent S Rose
PSA Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age-Limits for Recommended Screening. The Journal of urology (2024)
Paul J Riviere, Leah N Deshler, Kylie M Morgan, Edmund M Qiao, Alex K Bryant, Brent S Rose
Prostate-Specific Antigen Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age Limits for Recommended Screening. The Journal of urology (2024)
Paul J Riviere, Anna M Dornisch, Parag Sanghvi, Loren K Mell
Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials. Cancers 15 (23) (2023)
Paul J Riviere, Sandhya Kalavacherla, Matthew P Banegas, Juan F Javier-DesLoges, Maria Elena Martinez, Isla P Garraway, James D Murphy, Brent S Rose
Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes. Cancer (2022)
Casey W Williamson, Tyler J Nelson, Caroline A Thompson, Lucas K Vitzthum, Kaveh Zakeri, Paul J Riviere, Alex K Bryant, Andrew B Sharabi, Jingjing Zou, Loren K Mell
Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
Lucas K Vitzthum, Vinit Nalawade, Paul J Riviere, Mallika Marar, Timothy Furnish, Lewei A Lin, Reid F Thompson, James D Murphy
Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment. Journal of the National Cancer Institute 114 (5) (2022)
Reith R Sarkar, P Travis Courtney, Katie Bachand, Paige E Sheridan, Paul J Riviere, Zachary D Guss, Christian R Lopez, Michael G Brandel, Matthew P Banegas, James D Murphy
Quality of care at safety-net hospitals and the impact on pay-for-performance reimbursement. Cancer 126 (20) (2020)
Paul J Riviere, Elaine Luterstein, Abhishek Kumar, Lucas K Vitzthum, Rishi Deka, Reith R Sarkar, Alex K Bryant, Andrew Bruggeman, John P Einck, James D Murphy, María Elena Martínez, Brent S Rose
Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer 126 (8) (2020)
Reith R Sarkar, Sunil H Patel, J Kellogg Parsons, Rishi Deka, Abhishek Kumar, John P Einck, Arno J Mundt, A Karim Kader, Christopher J Kane, Paul J Riviere, Rana McKay, James D Murphy, Brent S Rose
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease. Prostate cancer and prostatic diseases 23 (4) (2020)
Paul J Riviere, Lucas K Vitzthum, Vinit Nalawade, Rishi Deka, Timothy Furnish, Loren K Mell, Brent S Rose, Mark Wallace, James D Murphy
Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer 127 (9) (2020)
Paul J Riviere, Aaron M Goodman, Ryosuke Okamura, Donald A Barkauskas, Theresa J Whitchurch, Suzanna Lee, Noor Khalid, Rachel Collier, Manvita Mareboina, Garrett M Frampton, David Fabrizio, Andrew B Sharabi, Shumei Kato, Razelle Kurzrock
High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. Molecular cancer therapeutics 19 (10) (2020)
Paul J Riviere, Brent S Rose
Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer. Cancer 126 (18) (2020)
Rishi Deka, J Kellogg Parsons, Daniel R Simpson, Paul J Riviere, Vinit Nalawade, Lucas K Vitzthum, A Karim Kader, Christopher J Kane, Chelsea S Rock, James D Murphy, Brent S Rose
African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate cancer and prostatic diseases 23 (4) (2020)
Abhishek Kumar, Paul J Riviere, Elaine Luterstein, Vinit Nalawade, Lucas Vitzthum, Reith R Sarkar, Alex K Bryant, John P Einck, Arno J Mundt, James D Murphy, Brent S Rose
Associations among statins, preventive care, and prostate cancer mortality. Prostate cancer and prostatic diseases 23 (3) (2020)
Paul J Riviere, Abhishek Kumar, Elaine Luterstein, Lucas K Vitzthum, Vinit Nalawade, Reith R Sarkar, Alex K Bryant, John P Einck, Arno J Mundt, James D Murphy, Brent S Rose
Tobacco smoking and death from prostate cancer in US veterans. Prostate cancer and prostatic diseases 23 (2) (2019)

Paul J Riviere.css-eqlu8i{font-size:small;padding-left:4px;} (Paul Riviere)

Publication Activity (10 Years)

Top Topics

Top Venues

Paul J Riviere (Paul Riviere)